Molecular Formula | C13 H10 F3 N3 O |
Molar Mass | 281.23 |
Density | 1.425±0.06 g/cm3(Predicted) |
Boling Point | 360.8±42.0 °C(Predicted) |
Solubility | DMSO: 10 mg/mL;ethanol: 5 mg/mL |
Appearance | Off-white solid |
pKa | 11.02±0.70(Predicted) |
Storage Condition | +2C to +8C |
In vitro study | TFAP is a selective cyclooxygenase-1 (COX-1) inhibitor, with an IC 50 of 0.8 μM, while that against COX-2 is over 200 μM. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.556 ml | 17.779 ml | 35.558 ml |
5 mM | 0.711 ml | 3.556 ml | 7.112 ml |
10 mM | 0.356 ml | 1.778 ml | 3.556 ml |
5 mM | 0.071 ml | 0.356 ml | 0.711 ml |
biological activity | TFAP (N-(5-Aminopyridin-2-yl)-4-(trifluoromethyl)benzamide) it is a cell-permeable selective cyclooxygenase-1 (COX-1) inhibitor with an IC50 value of 0.8 μm. |
Target | Value |
COX-1 (Cell-free assay) | 0.8 μM |